Home › Lymphedema › NCT06144164
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
RecruitingPhase 3
A Prospective Cohort Study of Patients Undergoing ALND for Treatment of Breast Cancer: The Efficacy of a Comprehensive Prevention Program in Decreasing the Incidence of Lymphedema and Improving Quality of Life
Who can join
Ages 18 to 75 · Women
Full eligibility criteria
Inclusion Criteria: * Female sex * Diagnosis of breast cancer * Ages 18 to 75 years * Consented for unilateral ALND or for unilateral SLNB with possible ALND Exclusion Criteria: * Male sex * Does not speak English * Does not fit into study garment * Axillary recurrence * History of ALND * Requirement of bilateral ALND for the treatment of breast cancer * Treatment with SLNB only * Known anaphylactic allergy to ICG dye used in ILR * Impaired decision-making capacity
About the study
The purpose of this study to test whether a comprehensive program may help the lymph fluid to drain out of the arm and prevent lymphedema in participants with breast cancer.
What is being tested
- Immediate Lymphatic Reconstruction (procedure)
- Volumetric arm measurements (diagnostic test)
- Lymphatic massage (other)
- Range of motion exercises (other)
- Compression garment use (other)
Sponsor: Memorial Sloan Kettering Cancer Center · Participants: 285 · Started: Nov 16, 2023
Contact the study team
- Michelle Coriddi, MD · Phone: 646-608-8042
- Babak Mahrara, MD · Phone: 646-608-8085
Official record on ClinicalTrials.gov — NCT06144164
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.